The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: Toward a dynamic, aspirin augmented, test of gut mucosal permeability

Neurogastroenterology and Motility

Volumn 24, Issue 9, 2012, Pages

  Sequeira, I R ^a   Lentle, R G ^a   Kruger, M C ^a   Hurst, R D ^b  

^a MASSEY UNIVERSITY   (New Zealand)

^b THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

Aspirin; Intestinal permeability; Lactulose; Mannitol

Indexed keywords

ACETYLSALICYLIC ACID; LACTULOSE; MANNITOL;

ABSORPTION; ADULT; ARTICLE; CROHN DISEASE; DOSE RESPONSE; DRUG ABSORPTION; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE MUCOSA PERMEABILITY; NORMAL HUMAN; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; SINGLE DRUG DOSE; SMOKING; URINALYSIS; URODYNAMICS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LACTULOSE; MANNITOL; PERMEABILITY; SMOKING; TIME FACTORS; URINE;

EID: 84865438249     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01969.x     Document Type: Article

References (55)

1. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004; 4: 953-64.
2. Brenchley JM, Price DA, Schacker TW et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-71.
3. Lentle RG, Jansen PWM. Physical Processes of Digestion. New York, NY: Springer Verlag, 2011.
4. Fihn B-M, Sjoqvist A, Jodal M. Permeability of the rat small intestinal epithelium along the villus-crypt axis: Effects of glucose transport. Gastroenterology 2000; 119: 1029-36.
5. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55: 1512-20.
6. Pappenheimer JR. On the coupling of membrane digestion with intestinal absorption of sugars and amino acids. Am J Physiol Gastrointest Liver Physiol 1993; 265: G409-17.
7. Pappenheimer J, Reiss K. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J Membrane Biol 1987; 100: 123-36.
8. Shen L, Su LP, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009; 27: 443-9.
9. Wright EM, Martín MG, Turk E. Intestinal absorption in health and disease - sugars. Best Pract Res Clin Gastroenterol 2003; 17: 943-56.
10. Lichtenberger LM, Zhou Y, Dial EJ, Raphael RM. NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol 2006; 58: 1421-8.
11. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002; 34: 385-96.
12. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 416-22.
13. Camilleri M, Nadeau A, Lamsam J et al. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motility 2010; 22: e15-26.
14. Dastych M, Novotná H, Číhalová J. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Dig Dis Sci 2008; 53: 2789-92.
15. Markov A, Veshnyakova A, Fromm M, Amasheh M, Amasheh S. Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine. J Comparat Physiol B Biochem Syst Environ Physiol 2010; 180: 591-8.
16. Rao AS, Camilleri M, Eckert DJ et al. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol 2011; 301: G919-28.
17. Lentle RG, Janssen PWM. Physical characteristics of digesta and their influence on flow and mixing in the mammalian intestine: a review. J Comparat Physiol B Biochem Syst Environ Physiol 2008; B178: 673-90.
18. Siegel JA, Urbain JL, Adler LP et al. Biphasic nature of gastric emptying. Gut 1988; 29: 85-9.
19. Söderholm JD, Olaison G, Lindberg E et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut 1999; 44: 96-100.
20. Smecuol E, Pinto Sanchez MI, Suarez A et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009; 7: 524-9.
21. Lambert GP, Boylan M, Laventure JP, Bull A, Lanspa S. Effect of aspirin and ibuprofen on GI permeability during exercise. Internat J Sports Med 2007; 28: 722-6.
22. Farhadi A, Keshavarzian A, Kwasny MJ et al. Effects of aspirin on gastroduodenal permeability in alcoholics and controls. Alcohol 2010; 44: 447-56.
23. Nishida U, Kato M, Nishida M et al. Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration. J Clin Biochem Nutrition 2011; 48: 245-50.
24. Suenaert P, Bulteel V, Den HE et al. The effects of smoking and indomethacin on small intestinal permeability. Alimentary Pharmacol Therap 2000; 14: 819-22.
25. Prytz H, Benoni C, Tagesson C. Does Smoking Tighten the Gut? Scand J Gastroenterol 1989; 24: 1084-8.
26. Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohn's Colitis 2012; doi:10.1016/j.crohns.2011.12.010 (in press).
27. Cottone M, Georgios A, Sinagra E. Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis. Inflammatory Bowel Dis 2011; 17: 2213.
28. McGilligan VE, Wallace JMW, Heavey PM, Ridley DL, Rowland IR. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflammatory Bowel Dis 2007; 13: 108-15.
29. McGilligan VE, Wallace JMW, Heavey PM, Ridley DL, Rowland IR. The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers. Food Chemical Toxicol 2007; 45: 1593-8.
30. Bergeron V, Grondin V, Rajca S et al. Current smoking differentially affects blood mononuclear cells from patients with crohn's disease and ulcerative colitis: Relevance to its adverse role in the disease. Inflammatory Bowel Dis 2011; 18: 1101-11.
31. El-Tawil A. Smoking and inflammatory bowel diseases: what in smoking alters the course? Internat J Colorectal Dis 2010; 25: 671-80.
32. Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J. Effects of light smoking consumption on the clinical course of Crohn's disease. Inflammatory Bowel Dis 2009; 15: 734-41.
33. Pihan G, Regillo C, Szabo S. Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury. Dig Dis Sci 1987; 32: 1395-401.
34. Smecuol E, Bai JC, Sugai E et al. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001; 49: 650-5.
35. Van Nieuwenhoven MA, Geerling BJ, Deutz NEP, Brouns F, Brummer RJM. The sensitivity of the lactulose/rhamnose gut permeability test. European J Clin Investigat 1999; 29: 160-5.
36. Dawson DA, Archer L. Gender differences in alcohol consumption: effects of measurement. Br J Addiction 1992; 87: 119-23.
37. Gritz ER, Thompson B, Emmons K, Ockene JK, McLerran DF, Nielsen IR. Gender differences among smokers and quitters in the Working Well Trial. Preventive Med 1998; 27: 553-61.
38. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009; 124: 3-20.
39. Pals KL, Chang R-T, Ryan AJ, Gisolfi CV. Effect of running intensity on intestinal permeability. J Applied Physiol 1997; 82: 571-6.
40. Nieuwenhoven M, Brouns F, Brummer R-J. Gastrointestinal profile of symptomatic athletes at rest and during physical exercise. European J Applied Physiol 2004; 91: 429-34.
41. Trehan I, Shulman RJ, Ou C-N, Maleta K, Manary MJ. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol 2009; 104: 2326-33.
42. Wilkinson L. Wiley interdisciplinary reviews: computational statistics. SYSTAT 2010; 2: 256-7.
43. Andre C. Food allergy: objective diagnosis and test of therapeutic efficacy by measuring intestinal permeability. La Presse Med 1986; 15: 105-8.
44. Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau J, Vandermeer R. Differential in-vivo and in-vitro intestinal permeability to lactulose and mannitol in animals and humans - a hypothesis. Gastroenterology 1995; 108: 687-96.
45. Bjarnason I. Intestinal permeability. Gut 1994; 35: S18-22.
46. Yu LX, Crison JR, Amidon GL. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Internat J Pharmaceutics 1996; 140: 111-8.
47. Yu LX, Amidon GL. Characterization of small intestinal transit time distribution in humans. Internat J Pharmaceutics 1998; 171: 157-63.
48. Malagelada J, Robertson J, Brown M et al. Intestinal transit of solid and liquid components of a meal in health. Gastroenterology 1984; 87: 1255.
49. Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010; 3: 247-59.
50. Mattioli F, Fucile C, Marini V et al. Assessment of intestinal permeability using sugar probes: influence of urinary volume. Clin laboratory 2011; 57: 909.
51. Somasundaram S, Sigthorsson G, Simpson R et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Alimentary Pharmacol Therap 2000; 14: 639-50.
52. Meyer RA, McGinley D, Posalaky Z. Effects of Aspirin on tight junction structure of the canine gastric-mucosa. Gastroenterology 1986; 91: 351-9.
53. Nathavitharana KA, Lloyd DR, Raafat F, Brown GA, McNeish AS. Urinary mannitol: lactulose excretion ratios and jejunal mucosal structure. Arch Dis Childhood 1988; 63: 1054-9.
54. Suenaert P, Bulteel V, Hond ED et al. In vivo Influence of Nicotine on Human Basal and NSAID-induced Gut Barrier Function. Scand J Gastroenterol 2003; 38: 399-408.
55. van Elburg RM, Uil JJ, Kokke FTM et al. Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. J Pediatric Gastroenterol Nutrition 1995; 20: 184-8.